Back

Multimodal assessment of disease progression risk among transthyretin amyloid cardiomyopathy patients under disease-modifying therapy

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: New insights into diagnosis of cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jan Wolfgang Groeschel

Charité - University Medicine Berlin, Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
Diverse anatomical and metabolic effects of amyloid deposits in transthyretin cardiac amyloidosis revealed by 3D reconstruction of serial block face-scanning electron microscopy images
Doctor S. Saito (Shimotsuke, JP)
Abstract Slides
Presentation thumbnail
Trajectory and prognostic significance of conduction system disease in cardiac transthyretin amyloidosis: a european multicenter cohort study
Doctor L. Schlender (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Targeted screening for transthyretin cardiac amyloidosis in severe aortic stenosis: development and validation of a clinical risk score
Assistant Professor A. Antonopoulos (Athens, GR)
Abstract Slides
Presentation thumbnail
Prognostic implications of Perugini Grading in a contemporary centre referral cohort undergoing evaluation for suspected cardiac amyloidosis
Ms N. Hartvig Jensen (DK)
Abstract Slides
Presentation thumbnail
Heterogeneity in cardiac amyloidosis care across Europe: a key opinion leader survey
Mr L. Kieviet (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
New insights into diagnosis of cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic utility of echocardiographic assessment in wild type transthyretin amyloid cardiomyopathy
22 May 2023
thumbnail
Congress Presentation
Amyloid progression or comorbidities? Differentiating management for optimal outcomes
31 August 2025
thumbnail
Congress Presentation
Monitoring transthyretin amyloidosis diseases using imaging
28 August 2026
thumbnail
Congress Presentation
Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathy in a prospective cohort study
11 December 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources